2013-03-07 Leadership Call

Owned by Jamie Thomas
Last updated: Apr 09, 2013Version comment
2 min read

Date

7 March 2012

How To Join

Contact @Paul Biondich for more information on how to join the call.

In Attendance

Agenda

  • Evaluation & Impact Role Overview - Hamish

  • Q&A

Meeting Minute

View at notes.openmrs.org

Attendees
Jamie Thomas
Hamish Fraser
Michael Seaton
Paul Biondich
Michael Downey
Chris Seebregts
Burke Mamlin
Darius Jazayeri

Agenda
Updates/AOB
Evaluation & Impact Role Overview - Hamish
Q&A

Minutes

  • Evaluation & Impact Role Overview - Hamish presented a slide show

    • System monitoring

      • system uptime

      • daily usage - forms, patient views, reports

      • data completeness and quality

      • user experience

      • link between performance, usability, impact and costs

    • System usability

      • UI

      • user testing and experience

      • workflow

      • assessment of high value deliverables

      • access to lab data

      • loss to follow up

      • registration and IO management

    • Q: How making the distinction between "evaluating the impact of OpenMRS implementations for care provision" and "evaluating the hard performance of OpenMRS" evaluating performance characterstics of OpenMRS?

      • A: There is a little bit of overlap but these things need to be thought about by our group.

    • clinical impact

      • quality of care

      • process variables

      • delays in lab results

      • delays in ording new labs

      • delays in starting Rx

      • outcome variables

      • ....

    • data use and reporting

      • what are we using data for - clinical care, reporting, supply chain, research etc.?

      • what tools are available?

      • what are key areas of interoperability for better data use (inputs and outputs)?

      • how do we make OMRS more easy to use and less of a black box for clinicians and researchers?

    • programmatic impact

      • reporting moh

      • clinic management

      • reporting to funders

      • cost data and estimates of consumption

      • drug supply forcasting

    • economic evaluation

      • initial costs of site set up

      • longer term costs

      • total cost of ownership

      • relationship between different inputs and overall performance

    • ethical issues

      • impact evaluation is a key issue for publication and funders

      • requires large and rigourius studies

      • concerns of conflict of intrest if system

      • ...

    • lessons learned

    • 2013 Goals

      • Carry out a survey of OpenMRS implementations to assess their experience with and needs for evaluation studies

      • Develop a guide to literature on eHealth systems that have shown clinical and programmatic impact in resource poor environments and how that evidence can be translated into better support for healthcare

      • Organize a one day meeting on eHealth evaluation and OpenMRS likely around the annual symposium

      • Identify 2 or more organizations that are committed to carrying out evaluation studies and provide advice and support where needed

      • Lead a strategic discussion on reporting and data access from OpenMRS

      • Lead development of tools for monitoring OpenMRS performance and use in the field along with a dashboard overview

  • Q&A:

    • 2013 Theme

    • get system recording and reporting in Rwanda

    • getting better at reporting key site requirements

    • understanding from tech perspective whether implementations are stable and what impact we have on that stability or lack of (adding this to lead bio on the wiki)

    • data completeness - implementation side and supportive activities for the data on the technical side

    • sub - community

    • evaluation work - eg. martin were

    • quality assurance types

    • performance module in rwanda (funded)

    • will be prioritize that omrs can evaluate behavior of live systems, aggragte and report back